ABS0467 INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER OPEN-LABEL STUDY OF 196 PATIENTS. | Publicación